Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-21

Clinical Trial Update: Safety of Topical Insulin Drops for Open-angle Glaucoma [Phase 1]

View source ↗

Summary

A Phase 1 study assesses the safety of topical insulin eye drops for open-angle glaucoma, with status currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical insulin eye drops (insulin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Glaucoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING